Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shenzhen Salubris Pharmaceuticals Co. Ltd.

www.salubris.com

Latest From Shenzhen Salubris Pharmaceuticals Co. Ltd.

Venture Funding Deals: Relay Closes Out 2018 With $400m Series C

2018 was a banner year for venture funding, and Relay's December Series C was only the third largest VC round of the year. Other year-end financings include Millendo, Erasca, Aristea and more... 

Deals Financing
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Shenzhen Salubris Pharmaceuticals Co. Ltd.
  • Senior Management
  • Kevin Ye, CEO
    Heng Xie, MD, PhD, CMO
  • Contact Info
  • Shenzhen Salubris Pharmaceuticals Co. Ltd.
    Phone: 755 83867888
    Fl. 37, Bldg. B, NEO Lvjing Sq., 6009
    Shennan Ave.
    Futian District,
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register